During the past decade, Jakobi Krankenhaus conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Jakobi Krankenhaus" are "Lymphoma" (3 trials), "Chronic Lymphocytic Leukemia" (1 trials) and "Leukemia" (1 trials). Many other conditions were trialed in "Jakobi Krankenhaus" in a lesser frequency.

Most popular intervention types in "Jakobi Krankenhaus" are "Drug" (5 trials), "Biological" (4 trials), "Radiation" (4 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (4 trials), "radiation therapy" (4 trials), "doxorubicin hydrochloride" (3 trials), "filgrastim" (3 trials) and "prednisone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Jakobi Krankenhaus" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Jakobi Krankenhaus". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Jakobi Krankenhaus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Jakobi Krankenhaus, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".